Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
Clinical trial NCT05417126 · COMPLETED
Trial details
- NCT number
- NCT05417126
- Sponsor
- Nanoscope Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2023-08-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.